Enzymatic biosynthesis of novel resveratrol glucoside and glycoside derivatives

Applied and Environmental Microbiology

Volumn 80, Issue 23, 2014, Pages 7235-7243

  Pandey, Ramesh Prasad ^a   Parajuli, Prakash ^a   Shin, Ju Yong ^a   Lee, Jisun ^b   Lee, Seul ^b   Hong, Young Soo ^c   Park, Yong Il ^b   Kim, Joong Su ^c   Sohng, Jae Kyung ^a  

^a SunMoon University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOLOGY; BIOCHEMISTRY; CARBOHYDRATES; GLUCOSE; GLYCOSIDES; SUGARS;

BACILLUS LICHENIFORMIS; CONVERSION RATES; D-GLUCOSE; DIPHOSPHATES; GLUCOSYLTRANSFERASES;

RESVERATROL;

ALCOHOL; BACTERIUM; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE; PHOSPHATE; SUGAR;

CARBOHYDRATE; GLUCURONOSYLTRANSFERASE; GLYCOSIDE; RECOMBINANT PROTEIN; RESVERATROL; STILBENE DERIVATIVE;

BACILLUS; CHEMISTRY; CYTOSOL; ENZYMOLOGY; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING;

BACILLUS; CARBOHYDRATES; CLONING, MOLECULAR; CYTOSOL; GENE EXPRESSION; GLUCURONOSYLTRANSFERASE; GLYCOSIDES; RECOMBINANT PROTEINS; STILBENES;

EID: 84910131022     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02076-14     Document Type: Article

References (75)

1. Roldán A, Palacios V, Caro I, Pérez L. 2003. Resveratrol content of Palomino fino grapes: influence of vintage and fungal infection. J. Agric. Food Chem. 51:1464-1468. http://dx.doi.org/10.1021/jf020774u.
2. Sanders TH, McMichael JRW, Hendrix KW. 2000. Occurrence of resveratrol in edible peanuts. J. Agric. Food Chem. 48:1243-1246. http://dx.doi.org/10.1021/jf990737b.
3. Lyons MM, Yu C, Toma RB, Cho SY, Reiboldt W, Lee J, Breemen RB. 2003. Resveratrol in raw and baked blueberries and bilberries. J. Agric. Food Chem. 51:5867-5870. http://dx.doi.org/10.1021/jf034150f.
4. Jerkovic V, Collin S. 2007. Occurrence of resveratrol and piceid in American and European hop cones. J. Agric. Food Chem. 55:8754-8758. http://dx.doi.org/10.1021/jf071792k.
5. Langcake P, Pryce RJ. 1976. The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol. Plant Pathol. 9:77-86. http://dx.doi.org/10.1016/0048-4059(76) 90077-1.
6. Roggero JP, Garciaparrilla C. 1995. Effects of ultraviolet irradiation on resveratrol and changes in resveratrol and various of its derivatives in the skins of ripening grapes. Sci. Aliments 15:411-422.
7. He S, Jiang L, Wu B, Pan Y, Sun C. 2009. Pallidol, a resveratrol dimer from red wine, is a selective singlet oxygen quencher. Biochem. Biophys. Res.Commun. 379:283-287. http://dx.doi.org/10.1016/j.bbrc.2008.12.039.
8. Ito T, Abe N, Oyama M, Tanaka T, Murata J, Darnaedi D, Linuma M. 2009. Two novel resveratrol trimers from Dipterocarpus grandiflorus. Helv. Chim. Acta 92:1203-1216. http://dx.doi.org/10.1002/hlca.200800429.
9. Soleas GJ, Diamandis EP, Goldberg DM. 1997. Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30:91-113. http://dx.doi.org/10.1016/S0009-9120(96)00155-5.
10. Orallo F. 2006. Biological effects of cis-versus trans-resveratrol, p 577-600. In Aggarwal BB, Shishodia S (ed), Resveratrol in health and disease. CRC Press, Boca Raton, FL.
11. Orallo F. 2006. Comparative studies of the antioxidant effects of cis-and trans-resveratrol. Curr. Med. Chem. 13:87-98. http://dx.doi.org/10.2174/092986706775197962.
12. Anisimova NY, Kiselevsky MV, Sosnov AV, Sadovnikov SV, Stankov IN, Gakh AA. 2011. Trans-, cis-, and dihydro-resveratrol: a comparative study. Chem. Cent. J. 5:88. http://dx.doi.org/10.1186/1752-153X-5-88.
13. King RE, Bomser JA, Min DB. 2006. Bioactivity of resveratrol. Compr. Rev. Food Sci. F 5:493-506. http://dx.doi.org/10.1111/j.1541-4337.2006.00001.x.
14. Stuart JA, Robb EL. 2013. Bioactive polyphenols from wine grapes. Springer, New York, NY.
15. Szkudelski T. 2006. Resveratrol inhibits insulin secretion from rat pancreatic islets. Eur. J. Pharmacol. 552:176-181. http://dx.doi.org/10.1016/j.ejphar.2006.09.046.
16. Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q. 2007. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 6:307-319. http://dx.doi.org/10.1016/j.cmet.2007.08.014.
17. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342. http://dx.doi.org/10.1038/nature05354.
18. Wang MJ, Huang HM, Hsieh SJ, Jeng KC, Kuo JS. 2001. Resveratrol inhibits interleukin-6 production in cortical mixed glial cells under hypoxia/hypoglycemia followed by reoxygenation. J. Neuroimmunol. 112: 28-34. http://dx.doi.org/10.1016/S0165-5728(00)00374-X.
19. Frémont L, Belguendouz L, Delpal S. 1999. Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci. 64:2511-2521. http://dx.doi.org/10.1016/S0024-3205(99)00209-X.
20. Pezzuto JM. 2008. Grapes and human health: a perspective. J. Agric. Food Chem. 56:6777-6784. http://dx.doi.org/10.1021/jf800898p.
21. Mizutani K, Ikeda K, Kawai Y, Yamori Y. 2000. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. 46:78-83. http://dx.doi.org/10.3177/jnsv.46.78.
22. Bhatt SR, Lokhandwala MF, Banday AA. 2011. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur. J. Pharmacol. 667:258-264. http://dx.doi.org/10.1016/j.ejphar.2011.05.026.
23. Petrovski G, Gurusamy N, Das DK. 2011. Resveratrol in cardiovascular health and disease. Ann. N. Y. Acad. Sci. 1215:22-33. http://dx.doi.org/10.1111/j.1749-6632.2010.05843.x.
24. Sato M, Ray PS, Maulik G, Maulik N, Engelman RM, Bertelli AA, Bertelli A, Das DK. 2000. Myocardial protection with red wine extract. J. Cardiovasc. Pharmacol. 35:263-268. http://dx.doi.org/10.1097/00005344-200002000-00013.
25. Gorbunov N, Petrovski G, Gurusamy N, Ray D, Kim Do H, Das DK. 2012. Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells. J. Cell. Mol. Med. 16:174-184. http://dx.doi.org/10.1111/j.1582-4934.2011.01281.x.
26. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220. http://dx.doi.org/10.1126/science.275.5297.218.
27. Pangeni R, Sahni JK, Ali J, Sharma S, Baboota S. 2014. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin. Drug Deliv. 11:1285-1298. http://dx.doi.org/10.1517/17425247.2014.919253.
28. Tsai SH, Lin-Shiau SY, Lin JK. 1999. Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol. Br. J. Pharmacol. 126:673-680. http://dx.doi.org/10.1038/sj.bjp.0702357.
29. Wadsworth TL, Koop DR. 1999. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem. Pharmacol. 57:941-949. http://dx.doi.org/10.1016/S0006-2952(99)00002-7.
30. Feng YH, Zhou WL, Wu QL, Li XY, Zhao WM, Zou JP. 2002. Low dose of resveratrol enhanced immune response of mice. Acta Pharmacol. Sin. 23:893-897.
31. Knutson MD, Leeuwenburgh C. 2008. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr. Rev. 66:591-596. http://dx.doi.org/10.1111/j.1753-4887.2008.00109.x.
32. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148:421-433. http://dx.doi.org/10.1016/j.cell.2012.01.017.
33. Robb EL, Page MM, Wiens BE, Stuart JA. 2008. Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem. Biophys. Res. Commun. 367:406-412. http://dx.doi.org/10.1016/j.bbrc.2007.12.138.
34. Gatz SA, Wiesmüller L. 2008. Take a break-resveratrol in action on DNA. Carcinogenesis 29:321-332. http://dx.doi.org/10.1093/carcin/bgm276.
35. Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. 2011. Clinical trials of resveratrol. Ann. N. Y. Acad. Sci. 1215:161-169. http://dx.doi.org/10.1111/j.1749-6632.2010.05853.x.
36. Zein N, Sinha AM, McGahren WJ, Ellestad GA. 1988. Calicheamicin gamma 1I: an antitumor antibiotic that cleaves double-stranded DNA site specifically. Science 240:1198-1201. http://dx.doi.org/10.1126/science.3240341.
37. Tan C, Tasaka H, Yu KP, Murphy ML, Karnofsky DA. 1967. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer 20:333-353.
38. Schatz A, Bugie E, Waksman SA. 1944. Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. Exp. Biol. Med. 55:66-69. http://dx.doi.org/10.3181/00379727-55-14461.
39. Griffith RS. 1981. Session I: history, bacteriology, and animal toxicity: introduction to vancomycin. Clin. Infect. Dis. 3:S200-S204.
40. Radford DJ, Gillies AD, Hinds JA, Duffy P. 1986. Naturally occurring cardiac glycosides. Med. J. Aust. 144:540-544.
41. Abu-Salah KM. 1996. Amphotericin B: an update. Br. J. Biomed. Sci. 53:122-133.
42. Weymouth-Wilson AC. 1997. The role of carbohydrates in biologically active natural products. Nat. Prod. Rep. 14:99-110. http://dx.doi.org/10.1039/np9971400099.
43. Thorson JS, Barton WA, Hoffmeister D, Albermann C, Nikolov DB. 2004. Structure-based enzyme engineering and its impact on in vitro glycorandomization. Chembiochem 5:16-25. http://dx.doi.org/10.1002/cbic.200300620.
44. Langenhan JM, Peters NR, Guzei IA, Hoffmann FM, Thorson JS. 2005. Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization. Proc. Natl. Acad. Sci. U. S. A. 102:12305-12310. http://dx.doi.org/10.1073/pnas.0503270102.
45. Albermann C, Soriano A, Jiang J, Vollmer H, Biggins JB, Barton WA, Lesniak J, Nikolov DB, Thorson JS. 2003. Substrate specificity of NovM: implications for novobiocin biosynthesis and glycorandomization. Org. Lett. 5:933-936. http://dx.doi.org/10.1021/ol0341086.
46. Fu X, Albermann C, Zhang C, Thorson JS. 2005. Diversifying vancomycin via chemoenzymatic strategies. Org. Lett. 7:1513-1515. http://dx.doi.org/10.1021/ol0501626.
47. Ahmed A, Peters NR, Fitzgerald MK, Watson JA, Jr, Hoffmann FM, Thorson JS. 2006. Colchicine glycorandomization influences cytotoxicity and mechanism of action. J. Am. Chem. Soc. 128:14224-14225. http://dx.doi.org/10.1021/ja064686s.
48. Williams GJ, Yang J, Zhang C, Thorson JS. 2011. Recombinant E. coli prototype strains for in vivo glycorandomization. ACS Chem. Biol. 6:95-100. http://dx.doi.org/10.1021/cb100267k.
49. Gantt RW, Peltier-Pain P, Cournoyer WJ, Thorson JS. 2011. Using simple donors to drive the equilibria of glycosyltransferase-catalyzed reactions. Nat. Chem. Biol. 7:685-691. http://dx.doi.org/10.1038/nchembio.638.
50. Gantt RW, Peltier-Pain P, Singh S, Zhou M, Thorson JS. 2013. Broadening the scope of glycosyltransferase-catalyzed sugar nucleotide synthesis. Proc. Natl. Acad. Sci. U. S. A. 110:7648-7653. http://dx.doi.org/10.1073/pnas.1220220110.
51. Park SH, Park HY, Sohng JK, Lee HC, Liou K, Yoon YJ, Kim BG. 2009. Expanding substrate specificity of GT-B fold glycosyltransferase via domain swapping and high-throughput screening. Biotechnol. Bioeng. 102: 988-994. http://dx.doi.org/10.1002/bit.22150.
52. Wu CZ, Jang JH, Woo M, Ahn JS, Kim JS, Hong YS. 2012. Enzymatic glycosylation of nonbenzoquinone geldanamycin analogs via Bacillus UDP-glycosyltransferase. Appl. Environ. Microbiol. 78:7680-7686. http://dx.doi.org/10.1128/AEM.02004-12.
53. Parajuli P, Pandey RP, Koirala N, Yoon YJ, Kim BG, Sohng JK. 2014. Enzymatic synthesis of epothilone A glycosides. AMB Express 4:31. http://dx.doi.org/10.1186/s13568-014-0031-1.
54. Pandey RP, Gurung RB, Parajuli P, Koirala N, Tuoi Le T, Sohng JK. 2014. Assessing acceptor substrate promiscuity of YjiC-mediated glycosylation toward flavonoids. Carbohydr. Res. 393:26-31. http://dx.doi.org/10.1016/j.carres.2014.03.011.
55. Pandey RP, Parajuli P, Koirala N, Park JW, Sohng JK. 2013. Probing 3-hydroxyflavone for in vitro glycorandomization of flavonols by YjiC. Appl. Environ. Microbiol. 79:6833-6838. http://dx.doi.org/10.1128/AEM.02057-13.
56. Pandey RP, Li TF, Kim EH, Yamaguchi T, Park YI, Kim JS, Sohng JK. 2013. Enzymatic synthesis of novel phloretin glucosides. Appl. Environ. Microbiol. 79:3516-3521. http://dx.doi.org/10.1128/AEM.00409-13.
57. Pandey RP, Parajuli P, Koirala N, Lee JH, Park YI, Sohng JK. 2014. Glucosylation of isoflavonoids in engineered Escherichia coli. Mol. Cells 37:172-177. http://dx.doi.org/10.14348/molcells.2014.2348.
58. Bhattarai S, Liou K, Oh TJ. 2012. Homology modeling and docking studies of Streptomyces peucetius CYP147F1 as limonene hydroxylase. J. Microbiol. Biotechnol. 22:917-922. http://dx.doi.org/10.4014/jmb.1112.12053.
59. Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M. 1995. Evaluation of comparative protein modeling by MODELLER. Proteins 23:318-326. http://dx.doi.org/10.1002/prot.340230306.
60. Maiti R, Van Domselaar GH, Zhang H, Wishart DS. 2004. SuperPose: a simple server for sophisticated structural superposition. Nucleic Acids Res. 32:W590-W594. http://dx.doi.org/10.1093/nar/gkh477.
61. Venkatachalam CM, Jiang X, Oldfield T, Waldman M. 2003. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J. Mol. Graph. Model. 21:289-307. http://dx.doi.org/10.1016/S1093-3263(02)00164-X.
62. Zhang Z, Yu B, Schmidt RR. 2006. Synthesis of mono-and di-O-β-Dglucopyranoside conjugates of (E)-resveratrol. Synthesis 8:1301-1306.
63. Zhou M, Hamza A, Zhan CG, Thorson JS. 2013. Assessing the regioselectivity of OleD-catalyzed glycosylation with a diverse set of acceptors. J. Nat. Prod. 76:279-286. http://dx.doi.org/10.1021/np300890h.
64. Larronde F, Richard T, Delaunay JC, Decendit A, Monti JP, Krisa S, Mérillon JM. 2005. New stilbenoid glucosides isolated from Vitis vinifera cell suspension cultures (cv. Cabernet Sauvignon). Planta Med. 71:888-890. http://dx.doi.org/10.1055/s-2005-871294.
65. Bolam DN, Roberts S, Proctor MR, Turkenburg JP, Dodson EJ, Martinez-Fleites C, Yang M, Davis BG, Davies GJ, Gilbert HJ. 2007. The crystal structure of two macrolide glycosyltransferases provides a blueprint for host cell antibiotic immunity. Proc. Natl. Acad. Sci. U. S. A. 104:5336-5341. http://dx.doi.org/10.1073/pnas.0607897104.
66. Quideau S, Deffieux D, Pouységu L. 2012. Resveratrol still has something to say about aging! Angew. Chem. Int. Ed. Engl. 51:6824-6826. http://dx.doi.org/10.1002/anie.201203059.
67. Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, Riera TV, Lee JE, E SY, Lamming DW, Pentelute BL, Schuman ER, Stevens LA, Ling AJ, Armour SM, Michan S, Zhao H, Jiang Y, Sweitzer SM, Blum CA, Disch JS, Ng PY, Howitz KT, Rolo AP, Hamuro Y, Moss J, Perni RB, Ellis JL, Vlasuk GP, Sinclair DA. 2013. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 339: 1216-1219. http://dx.doi.org/10.1126/science.1231097.
68. Yun JM, Chien A, Jialal I, Devaraj S. 2012. Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J. Nutr. Biochem. 23:699-705. http://dx.doi.org/10.1016/j.jnutbio.2011.03.012.
69. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. 2007. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 224:274-283. http://dx.doi.org/10.1016/j.taap.2006.12.025.
70. Wenzel E, Soldo T, Erbersdobler H, Somoza V. 2005. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol. Nutr. Food Res. 49:482-494. http://dx.doi.org/10.1002/mnfr.200500003.
71. Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. 2002. Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 50:3337-3340. http://dx.doi.org/10.1021/jf0112973.
72. Jones P, Vogt T. 2001. Glycosyltransferases in secondary plant metabolism: tranquilizers and stimulant controllers. Planta 213:164-174. http://dx.doi.org/10.1007/s004250000492.
73. Gachon CM, Langlois-Meurinne M, Saindrenan P. 2005. Plant secondary metabolism glycosyltransferases: the emerging functional analysis. Trends Plant Sci. 10:542-549. http://dx.doi.org/10.1016/j.tplants.2005.09.007.
74. Bowles D, Isayenkova J, Lim E, Poppenberger B. 2005. Glycosyltransferases: managers of small molecules. Curr. Opin. Plant Biol. 8:254-263. http://dx.doi.org/10.1016/j.pbi.2005.03.007.
75. Thorson JS, Vogt T. 2005. Glycosylated natural products, p 685-710. In Wong CH (ed), Carbohydrate-based drug discovery. Wiley-VCH, Weinheim, Germany.